Your browser doesn't support javascript.
loading
XRCC5/6 polymorphisms and their interactions with smoking, alcohol consumption, and sleep satisfaction in breast cancer risk: A Chinese multi-center study.
Yu, Li-Xiang; Liu, Li-Yuan; Xiang, Yu-Juan; Wang, Fei; Zhou, Fei; Huang, Shu-Ya; Zheng, Chao; Ye, Chun-Miao; Zhou, Wen-Zhong; Yin, Geng-Shen; Zhang, Jia-Lin; Cui, Shu-De; Tian, Fu-Guo; Fan, Zhi-Min; Geng, Cui-Zhi; Cao, Xu-Chen; Yang, Zhen-Lin; Wang, Xiang; Liang, Hong; Wang, Shu; Jiang, Hong-Chuan; Duan, Xue-Ning; Wang, Hai-Bo; Li, Guo-Lou; Wang, Qi-Tang; Zhang, Jian-Guo; Jin, Feng; Tang, Jin-Hai; Li, Liang; Zhu, Shi-Guang; Zuo, Wen-Shu; Ma, Zhong-Bing; Yu, Zhi-Gang.
  • Yu LX; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Liu LY; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Xiang YJ; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Wang F; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Zhou F; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Huang SY; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Zheng C; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Ye CM; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Zhou WZ; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Yin GS; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Zhang JL; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Cui SD; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Tian FG; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Fan ZM; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Geng CZ; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Cao XC; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Yang ZL; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Wang X; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Liang H; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Wang S; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Jiang HC; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Duan XN; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, China.
  • Wang HB; Department of Breast Surgery, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
  • Li GL; Department of Breast Surgery, Shanxi Cancer Hospital, Taiyuan, China.
  • Wang QT; Department of Breast Surgery, The First Hospital of Jilin University, Changchun, China.
  • Zhang JG; Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Jin F; Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Tang JH; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Binzhou Medical University, Binzhou, China.
  • Li L; Department of Breast Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Zhu SG; Department of General Surgery, Linyi People's Hospital, Linyi, China.
  • Zuo WS; Department of Breast Disease Center, Peking University People's Hospital, Beijing, China.
  • Ma ZB; Department of General Surgery, Beijing Chaoyang Hospital, Beijing, China.
  • Yu ZG; Department of Breast Disease Center, Peking University First Hospital, Beijing, China.
Cancer Med ; 10(8): 2752-2762, 2021 04.
Article en En | MEDLINE | ID: mdl-33734613
BACKGROUND: X-ray repair cross-complementary 5 (XRCC5) and 6 (XRCC6) are critical for DNA repair. Few studies have assessed their association with breast cancer risk, and related gene-environment interactions remain poorly understood. This study aimed to determine the influence of XRCC5/6 polymorphisms on breast cancer risk, and their interactions with cigarette smoking, alcohol consumption, and sleep satisfaction. METHODS: The study included 1039 patients with breast cancer and 1040 controls. Four single-nucleotide polymorphisms of XRCC5 and two of XRCC6 were genotyped. Information about smoking, alcohol consumption, and sleep satisfaction was collected through questionnaires. Odds ratios (OR) and related 95% confidence intervals (95% CI) were assessed using unconditional logistic regression models. Gene-environment interactions were analyzed using logistic regression with multiplicative interaction models. RESULTS: XRCC5 rs16855458 was associated with increased breast cancer risk in the co-dominant (ptrend  = 0.003) and dominant (CA + AA vs. CC, OR = 1.29, 95% CI = 1.07-1.56, p = 0.008) genetic models after Bonferroni correction. The CG + GG genotype of XRCC6 rs2267437 was associated with an increased risk of estrogen receptor-negative/progesterone receptor-negative (ER-/PR-) breast cancer (CG + GG vs. CC: OR = 1.54, 95% CI = 1.12-2.13, p = 0.008) after Bonferroni correction. Moreover, an antagonistic interaction between XRCC5 rs16855458 and alcohol consumption (pinteraction  = 0.017), and a synergistic interaction between XRCC6 rs2267437 and sleep satisfaction were associated with breast cancer risk (pinteraction  = 0.0497). However, these interactions became insignificant after Bonferroni correction. CONCLUSION: XRCC5 rs16855458 was associated with breast cancer risk, and XRCC6 rs2267437 was associated with the risk of ER-/PR- breast cancer. Breast cancer risk associated with XRCC5 and XRCC6 polymorphisms might vary according to alcohol consumption and sleep satisfaction, respectively, and merit further investigation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Consumo de Bebidas Alcohólicas / Fumar / Autoantígeno Ku Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Consumo de Bebidas Alcohólicas / Fumar / Autoantígeno Ku Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article